View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AB83 Publication ID: Spring 2025 
Title: Medical Marijuana and Cannabidiol Research Expansion 
Abstract:

Pursuant to Public Law 117-215, Medical Marijuana and Cannabidiol Research Expansion Act, passed on December 2, 2022, DEA plans on modifying its regulations related to the new application process and submission of supporting materials by electronic means only, through the Diversion Control Division secure online portal, for those who are manufacturing marijuana or cannabidiol for medical research and those who are conducting medical marijuana and cannabidiol research.

 
Agency: Department of Justice(DOJ)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Completed Actions 
Major: No  Unfunded Mandates: No 
EO 14192 Designation: Other 
CFR Citation: 21 CFR 1301   
Legal Authority: Pub. L. 117-215   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Withdrawn  04/21/2025 
Additional Information: Docket Number DEA-1132
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Information URL: DPW@dea.gov   Public Comment URL: www.regulations.gov  
RIN Data Printed in the FR: No 
Agency Contact:
Heather E Achbach
Acting Section Chief, Regulatory Drafting and Support Section
Department of Justice
Drug Enforcement Administration
Diversion Control Division, 8701 Morrissette Drive,
Springfield, VA 22152
Phone:571 387-3185
Email: heather.e.achbach@dea.gov